250 related articles for article (PubMed ID: 27294357)
41. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
42. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
[TBL] [Abstract][Full Text] [Related]
43. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma.
Rubenstein JL; Wong VS; Kadoch C; Gao HX; Barajas R; Chen L; Josephson SA; Scott B; Douglas V; Maiti M; Kaplan LD; Treseler PA; Cha S; Hwang JH; Cinque P; Cyster JG; Lowell C
Blood; 2013 Jun; 121(23):4740-8. PubMed ID: 23570798
[TBL] [Abstract][Full Text] [Related]
44. [Clinical diagnostic significance of cerebrospinal fluid detection with flow cytometry in children acute lymphoblastic leukemia accompanied by central nervous system leukemia].
Yang WY; Wang HJ; Chen YM; Chen XJ; Zou Y; Guo Y; Wang SC; Liu TF; Zhu XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):38-42. PubMed ID: 22391161
[TBL] [Abstract][Full Text] [Related]
45. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
[TBL] [Abstract][Full Text] [Related]
46. Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
Zuccato JA; Patil V; Mansouri S; Voisin M; Chakravarthy A; Shen SY; Nassiri F; Mikolajewicz N; Trifoi M; Skakodub A; Zacharia B; Glantz M; De Carvalho DD; Mansouri A; Zadeh G
Neuro Oncol; 2023 Aug; 25(8):1452-1460. PubMed ID: 36455236
[TBL] [Abstract][Full Text] [Related]
47. Central Nervous System Lymphoma.
Shah T; Venur VA
Semin Neurol; 2023 Dec; 43(6):825-832. PubMed ID: 37995744
[TBL] [Abstract][Full Text] [Related]
48. Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Heger JM; Mattlener J; Schneider J; Gödel P; Sieg N; Ullrich F; Lewis R; Bucaciuc-Mracica T; Schwarz RF; Rueß D; Ruge MI; Montesinos-Rongen M; Deckert M; Blau T; Kutsch N; Balke-Want H; Weiss J; Becker K; Reinhardt HC; Hallek M; Borchmann P; von Tresckow B; Borchmann S
Blood; 2024 Feb; 143(6):522-534. PubMed ID: 37946299
[TBL] [Abstract][Full Text] [Related]
49. Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
Thaler FS; Laurent SA; Huber M; Mulazzani M; Dreyling M; Ködel U; Kümpfel T; Straube A; Meinl E; von Baumgarten L
Neuro Oncol; 2017 Nov; 19(12):1618-1627. PubMed ID: 28521029
[TBL] [Abstract][Full Text] [Related]
50. Central nervous system lymphoma: a morphological MRI study.
Koubska E; Weichet J; Malikova H
Neuro Endocrinol Lett; 2016 Sep; 37(4):318-324. PubMed ID: 27857050
[TBL] [Abstract][Full Text] [Related]
51. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
van Westrhenen A; Smidt LCA; Seute T; Nierkens S; Stork ACJ; Minnema MC; Snijders TJ
Br J Haematol; 2018 Aug; 182(3):384-403. PubMed ID: 29808930
[TBL] [Abstract][Full Text] [Related]
53. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma.
Ungureanu A; Le Garff-Tavernier M; Costopoulos M; Parratte T; Brinet A; Durand H; Gaultier C; Hurstel R; Alamome I; Sellal F; Ahle G
J Neurol; 2021 Aug; 268(8):2890-2894. PubMed ID: 33609156
[TBL] [Abstract][Full Text] [Related]
54. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
Lossos IS; Breuer R; Intrator O; Lossos A
Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
[TBL] [Abstract][Full Text] [Related]
55. Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma.
Strowd RE; Abuali IA; Grossman SA
CNS Oncol; 2015; 4(3):131-5. PubMed ID: 25905905
[TBL] [Abstract][Full Text] [Related]
56. Cerebrospinal fluid approach on neuro-oncology.
Gomes HR
Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
[TBL] [Abstract][Full Text] [Related]
57. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.
Mao X; Sun Y; Tang J
Neurol Sci; 2014 Feb; 35(2):233-8. PubMed ID: 23832112
[TBL] [Abstract][Full Text] [Related]
58. Osteopontin: its potential role in cancer of children and young adults.
Karpinsky G; Fatyga A; Krawczyk MA; Chamera M; Sande N; Szmyd D; Izycka-Swieszewska E; Bien E
Biomark Med; 2017 Apr; 11(4):389-402. PubMed ID: 28326824
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
Kivisäkk P; Healy BC; Francois K; Gandhi R; Gholipour T; Egorova S; Sevdalinova V; Quintana F; Chitnis T; Weiner HL; Khoury SJ
Mult Scler; 2014 Apr; 20(4):438-44. PubMed ID: 24005026
[TBL] [Abstract][Full Text] [Related]
60. Diagnostic Value and Prognosis Significance of Cerebrospinal Fluid Examination by Flow Cytometry in Pediatric Acute Lymphoblastic Leukemia.
Xue L; Shang Q; Lu A; Zuo Y; Ding M; Zhang L; Jia Y
Technol Cancer Res Treat; 2023; 22():15330338231181025. PubMed ID: 37350078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
